Moffitt logo

Clinical Trials Search

Clinical Trial 20113

Cancer Type: Malignant Hematology
Interventions:REGN5458 ()

Study Type: Treatment
Phase of Study: Phase I
Investigators:

  • Jason Brayer

Call 813-745-6100
or 1-800-679-0775
Overview

Study Title

Phase 1/2 FIH Study of Regn5458 (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma

Summary

Objective